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Summary 1-P-D-Arabinofuranosylcytosine (Ara-C) at a concentration which inhibits nuclear-DNA reduplica-
tion (0.05gM), enhances mitochondrial activities like respiration, in cells of a human leukaemic cell line Molt
4. While the specific activity of cytochrome c oxidase doubles in the course of the GI phase of the cell cycle in
control cells, in the presence of Ara-C G, phase cells begin to increase the enzyme activity earlier and show a
3-fold rise of the enzyme activity in the same period of time. This is explained by an enhanced expression of
the mitochondrial genome: the concentration of transcripts for the mitochondrially encoded subunit II of
cytochrome c oxidase increases. Inhibition of mitochondrial protein synthesis abolishes the Ara-C induced
effect on the specific activity ofcytochrome c oxidase activity. The concentration of transcripts of the nuclearly
encoded subunit IV of cytochrome c oxidase is the same as in control cells, and also the specific activity of the
mitochondrial enzyme citrate synthase, which is exclusively encoded on nuclear-DNA, is not affected by
Ara-C. Dysregulation in time and intensity of the expression of the mitochondrial relative to the nuclear
genome may impair cell function and reflect a till now neglected mechanism of Ara-C cytotoxicity.
1-p-D-Arabinofuranosylcytosine is the most potent drug in
the treatment of non-lymphocytic leukaemia. After uptake in
the cells Ara-C is phosphorylated to an active metabolite
Ara-C-triphosphate, which interferes with nuclear-DNA syn-
thesis and inhibits reduplication of the affected cells (Coz-
zarelli, 1977; Kufe et al., 1980; Woodcock, 1987). Although a
number of clinical and experimental data cannot be
explained by an effect of Ara-C exclusively on DNA syn-
thesis (Haanen et al., 1985; Valeriote, 1982), little is known
about effects that Ara-C may exert on other processes which
are of vital importance for the cells.
Mitochondria are indispensable for proper functioning of
the cell, providing the cell with energy by way of oxidative
phosphorylation. The active components of the oxidative
phosphorylating machinery are five multiprotein complexes
located in the inner mitochondrial (mt) membrane. The
genetic information for four of these enzymes is partly and
uniquely encoded on mt-DNA and partly on nuclear-DNA.
Among the mt-DNA encoded proteins are three subunits of
cytochrome c oxidase and two subunits of ATP synthase
(Mariottini et al., 1986). Transcription and translation of mt
genes takes place by mt specific systems (Anderson et al.,
1981). The remaining subunits of these mt proteins (e.g.
subunit IV of cytochrome c oxidase) are encoced on nuclear-
DNA, synthesised in the cytosol and imported into the
organelle. The products of the two genomes assemble within
the mitochondrion and give rise to respiratory enzymes
(Kroon & Van den Bogert, 1987, Schatz & Butow, 1983).
Other mt proteins such as citrate synthase are fully encoded
on nuclear-DNA. The synthesis of many proteins is restricted
to a specific cell cycle phase (Denhart et al., 1986), and this
cell cycle phase dependency may be an important factor in
the regulation of cell cycle progression.
Little information exists about the mechanisms which
direct the interaction between the biogenetic synthetic
activities of the mitochondria and the nucleocytoplasm (De
Vries & Van't Sant, 1983; White & Bohman, 1981). In cy-
cling cells mt biogenesis and mt-DNA reduplication must
match cell growth and division so that functional constancy
is preserved through cell generations. Reduplication of the mt
mass occurs in a sequential order in the course of the cell
cycle (Van den Bogert et al., 1988). The increase in activity of
mt enzymes involved in oxidative phosphorylation in un-
treated Molt 4 cells occurs in the early G, phase of the cell
cycle (Van den Bogert et al., 1988).
Previously we demonstrated that cells of a human
leukaemic Molt 4 cell line respond to Ara-C with an in-
creased accumulation of a mt specific dye (Haanen et al.,
1986) and the enhancement of mt specific enzymatic activities
(Muus et al., 1987). The present study demonstrates that
these effects occur very early in the G, phase of the cell cycle
and are the result of an enhanced rate of synthesis of the
mt-DNA encoded subunits ofcytochrome c oxidase, which in
turn is the reflection of an increased amount of mRNA for
the mt-DNA encoded subunit II (COX II) of the enzyme.
The effect if accompanied by an increased rate of mt respira-
tion.
Materials and methods
Cell culturing
Cells from the human leukaemic cell line Molt 4 were kept in
suspension culture at a concentration of 0.25-1.0 x 106
cells ml-' in RPMI 1640 medium (Boehringer, Mannheim,
Germany), supplemented with 10% heat-inactivated foetal
calf serum (Gibco, Grand Island, NY, USA) 100 IU ml-'
penicillin, 100 jig ml-' streptomycin and 2mM L-glutamine
(Flow Laboratories, Irvine, Ayrshire, Scotland) (complete
medium) in a 5% C02-humidified atmosphere at 37°C.
Exponentially growing cells were used in the experiments.
Respiratory rate
After 12 h of culturing with or without Ara-C (0.05 gM) Molt
4 cells (concentration 4 x 10 cells ml-') were washed and
resuspended in medium containing 0.25 M sucrose, 2 mM
potassium phosphate, 20 mM Tris-HCl (pH.7.4) and 10 mM
MgCl2. An aliquot of this cell suspension was introduced into
an oxygraph and respiration rates were measured in a closed
system at 30°C, using a Clark type of oxygen electrode
(Granger & Lehninger, 1982). The effect of inhibitors of
electron transport at various sites in the respiratory chain
was analysed (amobarbital 1 mM, malonate 5 mM or potas-
sium cyanide 1 mM). The effects of inhibition of mt ATP-
synthase activity (oligomycin, 0.5gM) and an uncoupler
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(2,4-dinitrophenol, DNP, 1 mM) weA measured also. Oxygen
consumption was measured as described by Granger and
Lehninger for L 1210 cells (1982). Small amounts ofdigitonin
were added to permealise the cellular membranes for respira-
tory substrates e.g. succinate and glutamate and for inhibi-
tors of respiration. We found in Molt 4 cells no influence on
the rate of respiration by the addition of digitonin, which
was thereafter omitted.
Cell synchronisation
Enrichment for cells in the GI phase of the cell cycle was
accomplished by counterflow centrifugation (Vierwinden et
al., 1982, De Witte et al., 1984). A counterflow centrifuge
(Dijkstra, Bredevoort, The Netherlands) with a multichamber
rotor as developed by Plas et al. (1988) equipped with two
standard separation chambers was used. Aliquots of 5 x 10'
cells were introduced into each chamber. Cells collected at a
decreasing rotor speed show a progressively larger cell
volume and represent distinct populations of cells in transi-
tion from the G, phase, through S phase up to the G2M
phase. On the basis of the DNA histograms obtained by
flowcytometry, fractions were selected which contained
>95% cells in the GI phase. Cells were resuspended in
complete medium at 37°C with the appropriate concentration
of drugs at time t = 0.
DNAflowcytometry
A sample of 104 cells of each subfraction was stained with a
hypotonic propidium iodide solution according to Krishan
(1975) containing: 25 gg ml-' propidium iodide (Calbiochem,
San Diego, CA), 0.1% w/v tri-sodium citrate dihydrate
(Merck, Darmstadt, Germany), 10% v/v RNA-se solution
(RNA-se A, Sigma, St Louis, MO, 1 mgml' in phosphate
buffered saline with 0.5 mM EDTA) and 0.1% v/v Triton
X-100 in distilled water. The DNA content was assessed by
measuring the relative fluorescence of the cells in a 30H
Cytofluorograph (Ortho Diagnostic Systems, Westwood,
MA). The 488 nm line of a 5-W argon ion laser at 0.4 W
output was used for excitation and a high-pass RG630 nm
filter for red fluorescence. The percentages of the cells with
2n, 2<n<4 and 4n DNA were calculated according to
Gohde (1973) and Van Egmond and Hillen (1978).
Drug exposure
Ara-C was a gift from the Upjohn Company (Kalamazoo,
MI, USA). As a specific inhibitor of mitochondrial protein
synthesis doxycycline (10 gml-') was used (Kroon & Van
den Bogert, 1983). Doxycycline was purchased from Pfizer,
Rotterdam, The Netherlands. Cells were grown in suspension
cultures in the presence of Ara-C (0.05 EM) or doxycycline
(10tLg ml-') or both. Cell concentration at t = 0 was 4 x 105
cells ml-'. At various time intervals as indicated under
results, separate flasks containing cultures of Ara-C treated
or control cells were placed on ice. Cells were counted using
a Coulter Counter (Model ZM, Coulter Counter Ltd, Luton,
Beds., England), washed and resuspended in ice-cold phos-
phate buffered saline (PBS). Aliquots were taken for
immediate assessment of the DNA histogram and the
capacity to accumulate a mt specific dye.
Extracts of cell samples were cryopreserved until measure-
ment of the amount of ATP and ADP. To measure activities
of mitochondrial enzymes and cellular protein content, cell
samples were stored at - 20°C until later analysis.
Measurement ofthe uptake ofa mt specific dye and ofthe cell
size
The accumulation of mt specific dye 3,3-dipentyloxacarbo-
cyanine (Di-O-C(5)3) (Johnson et al., 1981) was measured by
flow cytometry. Di-O-C(5)3 was obtained from Molecular
Probes (Junction City, Oregon, USA). Measurement of
fluorescence was performed under standardised conditions as
described earlier (Haanen et al., 1986). In short, cells were
exposed to Di-O-C(5)3 (2.0glgml-') for 15 min; hereafter
fluorescence was induced by excitation at 488 nm and
measured at 520 nm. Cell size was monitored by red forward
light scatter (RFS), which was measured simultaneously with
Di-O-C(5)3 fluorescence as described under DNA flowcyto-
metry.
Total cellular protein andenzymatic activities ofcytochrome c
oxidase and citrate synthase
Cytochrome c oxidase activity (Borst et al., 1967) and citrate
synthase activity (Srere, 1969) were measured spectro-
photometricaly at 20°C using a Beckman DU-7 spectro-
photometer, equipped with a time-drive program. Activities
were expressed as the first-order reaction rate constant K per
number of cells per min (cytochrome c oxidase), or as ftmol
of the product formed per number of cells per min (citrate
synthase). Cellular protein was assessed using a modification
of the method of Lowry et al. (Peterson, 1977).
ATP and ADPpools
A known number of cells were pelleted and the nucleotides
were extracted in 0.4M perchloric acid. The extract was
neutralised with 1 M K2HPO4/0.4M KOH and stored at
- 20°C until analysis. Simultaneous analysis of ATP and
ADP was performed according to a modification of the
method of Solomons et al. (1977) by isocratic reverse-phase
high pressure liquid chromatography (HPLC), using a
ft-Bondapak C8 column and 0.1 M KH2PO4 (pH 4.6) as
eluens.
Isolation and blotting oftotal cellular RNA
Total cellular RNA was isolated according to the method as
described by Birnboim (1988). Sonification was done with a
Branson sonifier cell disrupter type B15. RNA samples were
glyoxylated and run in 1.25% agarose gel in 10 mM sodium
phosphate buffer pH = 6.5. RNA was blotted on Gene
Screen Plus with a Vacu-Blot apparatus (LKB, 2016
Vacugene Vacuum Blotting Unit) during 2 h by 0.04 bar in
20 x SSC (1 x SSC = 0.15 M sodium chloride + 0.015 M
sodiumcitrate).
Hybridisation with radioactive DNA probes
Hybridisation was performed according to Church and
Gilbert (1984) at 65°C. The probes were labelled with 32P-
dCTP to a specific activity of about 5 x 108 c.p.m.pg-' using
the random primer technique developed by Feinberg and
Vogelstein (1983). The following probes were used: an Xbal
fragment of human placental mt-DNA containing the entire
gene for subunit II ofcytochrome c oxidase (COX II), cloned
into pUC 19 and a cDNA clone of the nuclear coded subunit
IV of human cytochrome c oxidase (COX IV), a kind gift
from Dr Margaret Lomax.
Results
Respiration ofMolt 4 cells exposed to Ara-C
After 12 h of culturing in the presence of Ara-C, cell
numbers were unaltered whereas in the same time the
number of control cells had increased 1.4-fold.
In control Molt 4 cells and in Ara-C exposed cells the
respiration was 55% inhibited by amobarbital (a specific
inhibitor of NADH coenzyme Q reductase), whereas subse-
quent addition of malonate, an inhibitor of succinate
dehydrogenase did not cause a further depression of respira-
tion. This data indicates that respiration of Molt 4 cells is
mainly linked to complex I, and is thus depending on
NADH. Respiration of Molt 4 cells was almost completely
inhibited by KCN or oligomycin. The latter effect could beARA-C ENHANCES MITOCHONDRIAL ACTIVITIES 31
abrogated by the addition of DNP. Taken together, the
observed oxygen consumption by Ara-C treated and control
Molt 4 cells is predominantly the expression of mt respiration
coupled to ATP synthesis.
Ara-C treatment (0.05tLM, 12 h) stimulated respiration.
The respiratory rate in Ara-C treated cells was 266 ± 15 ng
atomic oxygen min' 10-8 cells vs 191 ± lOng atomic
oxygen min-' 1o-8 cells in controls (n = 3). In these experi-
ments cytochrome c oxidase activity was 32.6 K min'- 10-9
cells in Ara-C treated cells vs 21.3 Kmin-' 10-9 cells in
controls. The enhanced cytochrome c oxidase activity in
Ara-C treated Molt 4 cells is accompanied by a higher
oxygen consumption due to an enhanced mt respiration.
Synchronisation ofthe cells
The GI phase cell fraction used as a starting population for
synchronised cell cycle progression was at least 95% pure.
Upon reculturing the control cells reached the S phase at 9 h.
Fourteen per cent of the cells had entered the G2M phase
after approximately 1Oh (Figure 1).
When GI cells were cultured in the presence of Ara-C
(0.05 SAM) they did not exhibit an increase of cellular DNA
and cell numbers remained constant.
Effects ofAra-C upon mt activity in G, phase cells
Total protein and cell size The protein content of the cells
gradually rose from approximately 100 mg 10-' cells at t = 0
to 120 mg 10-' cells at t = 9 h. Until then no differences were
found between cellular protein in control cells and cells cul-
tured in the presence of Ara-C (Figure 2a). Beyond 9 h the
protein level in cells exposed to Ara-C continued to increase,
whereas in control cells no further increase was demon-
strated. The cell size as measured by flowcytometry appeared
similar in Ara-C treated cells and controls throughout the
12 h of follow-up (Figure 2b).
Cytochrome c oxidase activity GI cells in the starting
population (t = 0) showed a cytochrome c oxidase activity
of 8.4 ± 1.1 K min' 10' cells. As control GI cells pro-
gressed through the cell-cycle, the activity of cytochrome c
oxidase increased to a maximum value of approximately
17.5 K min- 1i0-9 cells at 9 h of culturing, when the
majority of the cells had arrived in S phase. Further, in the
course of the cell cycle, cytochrome c oxidase activity
remained more or less constant (Figure 3a). Cytochrome c
oxidase activity of GI cells cultured in the presence of
Ara-C continued to increase to a value of 26 K min'I0-9
cells after 12 h. Moreover the increase started at an earlier
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Figure 2 G, cells, separated by counterflow centrifugation, were
recultured in complete medium as controls (0), in the presence
of Ara-C (0.05fM) (0) and with both Ara-C (0.05gM) and
doxycycline (10lAgml-') (*). Protein content, a, and cell size, b,
were assessed at various time points after reculturing. Protein
content is expressed in mg 10-9 cells, cell size (RFS) in arbitrary
units. A representative experiment is shown.
point in time and proceeded at a higher rate in the Ara-C
treated cells (Figure 3a). The specific cytochrome c oxidase
activity (activity of cytochrome c oxidase per mg protein)
was also higher in the Ara-C exposed GI cells compared
with control cells (Figure 3b). In the presence of both
Ara-C and doxycycline, a specific inhibitor of mt protein
synthesis (Kroon & Van den Bogert, 1983), cell cycle pro-
gression was inhibited to the same as in the presence of
Ara-C alone (data not shown), but under these circums-
tances Ara-C did not enhance cytochrome c oxidase activity
(Figure 3a). The activity of the enzyme remained at the
level of GI cells in the starting population. The addition of
doxycycline had no influence on the increase of the cellular
protein content and the size of the cells during the 12 h of
follow-up (Figure 2a,b).
Hour
Control Ara-C
Figure 1 GI Molt 4 cells, separated by counterflow centrifugation, were recultured with or without Ara-C (0.05gM) for up to 12 h.
Series of DNA histograms in time show the progression of control GI cells through the cell cycle (left); on the right side the DNA
histograms at similar timepoints, when G, cells were cultured in the presence of Ara-C, are shown. Each DNA histogram is
graphically normalised to equal peak height. Abscissa: relative amount of cellular DNA; z-axis: subsequent time points; ordinate:
relative cell numbers.
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Figure 3 GI cells were separated by counterflow centrifugation
and regrown in complete medium in the presence of 0.05 iM
Ara-C (closed symbols), in the presence of both 0.05IM Ara-C
and 10gIgm -m doxycycline (*), or as controls (open symbols).
The activities of mt enzymes were measured at subsequent time
points during reculturing. a, activities ofcytochrome c oxidase on
a per cell base, expressed as absolute values (Kmin'I0-9 cells).
The data from two independent experiments is shown. b, enzyme
activities related to the total cellular protein content and ex-
pressed as specific activities: cytochrome c oxidase (0, *)
(K min ' mg'` protein) and citrate synthase (0,U) (jAmol
min' mg-' protein). The data from a representative example is
shown.
Citrate synthase activity Citrate synthase activity in Ara-C
treated cells both expressed per 1O'cells and per mg protein
(specific enzyme activity) did not rise above the activity in
control cells during the 12 h of exposure of G0 cells (Figure
3b).
ATP and ADP pools The level of ATP in control cells
increased throughout the G0 into the S phase from 3.4 to
6.3 nmol 10-6 cells. During the first 6 h of culturing the ATP
levels in Ara-C exposed GI phase cells and in control G0
phase cells increased at a comparable rate. From then
onward ATP levels of control cells declined, whereas in the
presence of Ara-C a further rise was observed till approxi-
mately 7.2 nmol 10-6 cells (Figure 4a). The ADP content of
control and Ara-C exposed cells slowly increased from
0.15 nmol 10-6 cells at t = 0 to 0.35 nmol 1-6 cells at
t = 10.5 h. For at least 10 h ADP pools were comparable in
the two groups (Figure 4b).
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Figure 4 GI cells were separated by counterflow centrifugation
and recultured in complete medium without Ara-C (0) or with
0.05 giM Ara-C (0). The concentrations of ATP a and ADP b in
the cells were determined at various time points; the values are
expressed in nmol 10-6 cells. A representative example is shown.
Uptake of a mt specific dye The increase in the capacity of
the cells to accumulate mt specific dye during the first 6 h of
Ara-C exposure was similar to that in control GI cells.
Beyond this time less dye was found to accumulate in control
cells, whereas Ara-C treated cells demonstrated a further
increase (Figure 5).
Levels oftranscripts ofthe genesfor subunit II (COX II) and
IV (COX IV) ofcytochrome c oxidase The amount of COX
II trancripts per gg toal cellular RNA was higher in the
Ara-C treated GI cells when compared with control G0 cells.
Already 45 min after exposure to Ara-C the amount of COX
II transcript was increased relative to that in control cells
(Figure 6, upper part). The concentration of the nuclear-
DNA encoded COX IV transcript per fig total cellular RNA
was similar in Ara-C treated cells and controls (Figure 6,
lower part). The amount of mt-DNA remained similar in
Ara-C treated cells and controls (data not shown).
Discussion
GI phase cells exposed to Ara-C at a concentration inhibitory
to cell proliferation, shown an increased respiration rate and
an enhanced activity of cytochrome c oxidase. Moreover
Ara-C treated GI cells display a higher capacity to
accumulate the mt specific dye Di-O-C(5)3. This suggests that
these G0 cells possess a larger mass of mt membranes and an
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Figure 5 GI cells were separated by counterflow centrifugation
and recultured in complete medium in the presence of 0.05 jM
Ara-C (0) or without Ara-C (0). The capacity of the cells to
accumulate mt specific dye Di-O-C(5)3 was assessd at various
points in the course of time.
treatment: None Ara-C
Cox 11 (mitochondrial)
transcript
Cox IV (nuclear)
transcript
Time (hours) 0.75 2.25 4.0 5.0 6.0 0.75 2.25 4.0 5.0 6.0
Figure 6 GI phase cells were obtained by counterflow centrifuga-
tion and recultured in complete medium in the presence of
0.05 luM Ara-C, or as controls. At different times of culturing
total RNA was extracted, separated, blotted (3 ;g per slot) and
hybridised to probes for the COX II mRNA (upper part) and for
the COX II mRNA (lower part). One and the same filter was
used for hybridisation with the COX II probe and, after dehy-
bridisation, for rehybridisation with the COX IV probe. To arrive
at comparable signals for both the COX II and the COX IV
mRNAs, an exposure time of I h was required for the COX II
probe and of 20 h for the COX IV probe.
increased total mt membrane potential and synthesise an
increased amount of ATP. The discrepancy in time between
the elevations of cytochrome c oxidase activity and the con-
centration of ATP may point at an enhanced turnover of
ATP during the early hours of Ara-C exposure.
Studies on the effect of specific inhibition of mt protein
synthesis and measurement of the concentration of the tran-
scripts of the mt encoded subunit of cytochrome c oxidase,
COX II, suggest that Ara-C induces cytochrome c oxidase
synthesis by an enhanced transcription and translation of the
mt genome. Since the mt genome is transcribed in total it is
likely that the synthesis of other polypeptides which are
encoded on mt-DNA, such as subunits of ATP synthase, is
stimulated as well. An observation in favour of this supposi-
tion is the enhanced respiratory rate in Ara-C treated cells.
Control G1 phase cells progress into the S phase while
Ara-C treated cells do not (Figure 1). However a number of
arguments favour the supposition that the enhanced mt
acivities observed are induced by Ara-C and are not second-
ary to perturbation of the cell cycle.
(1) Counterflow centrifugation provides an almost pure
suspension of viable GI phase cells, which also maintain a
high degree of synchronisation upon reculturing (Vierwinden
et al., 1982). Enhancement of cytochrome c oxidase activity
was observed already after exposure to Ara-C for only 1.5
and 3 h, while it took 9 h of reculturing, for the majority of
control GI phase cells to enter the S phase of the cell cycle.
(2) The few cells which entered S earlier than the majority
of the GI cells, could hypothetically be responsible for a
depression of cytochrome c oxidase activity in the control
sample. This is unlikely however, because it has been demon-
strated that the cytochrome c oxidase activity in untreated
Molt 4 cells increases during GI and remains at a plateau
level during the S phase of the cell cycle (Van den Bogert et
al., 1988).
The generally accepted mechanisms of Ara-C cytotoxicity
implying inhibition of nuclear-DNA polymerase and incor-
poration of the phosphorylated metabolite into nuclear-DNA
(Cozzarelli, 1977) can thus not acocunt for the observed
effects in early GI phase cells.
The observation that an increased amount of functioning
cytochrome c oxidase coexists with an enhanced concentra-
tion of the mRNAs of only those subunits which are encoded
on the mt genome (such as COX II) could indicate that there
is a surplus of nuclear-DNA encoded subunits (such as COX
IV), as was also suggested by Schatz (1968) and by Weiss
and Kolb (1979) and may suggest a regulatory role of the mt
genome products (Van den Bogert et al., 1988). It must be
stressed here, that the much higher copy number of mt
mRNAs per cell (such as COX II mRNA) in comparison
with that of the nuclear mRNAs for mt proteins (such as
COX IV mRNA) does not necessarily mean that mt mRNAs
are functionally in excess over the nuclear messengers (De
Vries et al., 1990). The very particular properties of mt
mRNAs (lacking ribosome-binding sites and leader
sequences), mt tRNAs (lacking loops that are essential in all
other systems) and mt ribosomes (having very small rRNAs
and a very high protein content) may well lead to a very slow
or inefficient translation process that is only able to function
when mRNA levels are high. Dysregulation in time or inten-
sity of the expression of the mt genome is therefore even
more likely to interfere with the function and survival of the
cell. Enhancement by Ara-C of the expression of mt-DNA in
G1 phase cells, implying such a dysregulation, could partly
explain earlier data suggesting a cytotoxic effect of Ara-C
exerted on non-S phase cells (Haanen et al., 1985; Valeriote,
1982).
If our data imply a type of unbalanced growth it indicates
that increased transcription and translation of mt-DNA must
be a very early or even initiating event. GI cells which were
inhibited by Ara-C in fact continued to increase in size and
outgrew control cells, be it measurable only after 10-12 h
(Figure 2). Our data is not in conffict with inhibition of
proliferation by an increased expression of differentiation
antigens. The phenomenon of cell differentiation is accom-
panied by an enhancement of mt activity and mt mass
(Pederson, 1978). Craig et al. (1984) provided strong evidence
that Ara-C induces differentiation in non-S phase cells of a
human leukaemic cell line. Reports in the literature on
differentiation induction by Ara-C are still conflicting (Sachs,
1978; Reiss et al., 1986).
We demonstrated that dysregulation in time and intensity
of the expression of the mt genome resulting in enhanced
oxidative phosphorylation occurred during the G1 phase of
the cell cycle and at Ara-C concentrations, which inhibit
nuclear-DNA synthesis and cell proliferation. The present
study does not allow conclusions about a causal relationship
between the effect of mt activities and the strong
antileukaemic effect of the drug. However, mt activity may
be an important target in attaining cytostasis (Van den
Bogert et al., 1986) or even cytotoxicity in GI phase cells and
deserves further investigation.
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